BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29386642)

  • 1. Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential.
    Wong TN; Miller CA; Jotte MRM; Bagegni N; Baty JD; Schmidt AP; Cashen AF; Duncavage EJ; Helton NM; Fiala M; Fulton RS; Heath SE; Janke M; Luber K; Westervelt P; Vij R; DiPersio JF; Welch JS; Graubert TA; Walter MJ; Ley TJ; Link DC
    Nat Commun; 2018 Jan; 9(1):455. PubMed ID: 29386642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy.
    Hsu JI; Dayaram T; Tovy A; De Braekeleer E; Jeong M; Wang F; Zhang J; Heffernan TP; Gera S; Kovacs JJ; Marszalek JR; Bristow C; Yan Y; Garcia-Manero G; Kantarjian H; Vassiliou G; Futreal PA; Donehower LA; Takahashi K; Goodell MA
    Cell Stem Cell; 2018 Nov; 23(5):700-713.e6. PubMed ID: 30388424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients.
    Zhang CRC; Nix D; Gregory M; Ciorba MA; Ostrander EL; Newberry RD; Spencer DH; Challen GA
    Exp Hematol; 2019 Dec; 80():36-41.e3. PubMed ID: 31812712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin.
    Martín I; Navarro B; Villamón E; Solano C; Serrano A; Calabuig M; Amat P; Domingo F; Abellán R; García F; Olivares MD; Chaves FJ; Tormo M; Hernández-Boluda JC
    Exp Mol Pathol; 2018 Aug; 105(1):139-143. PubMed ID: 30017658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent DNMT3A mutation burden in DNMT3A mutated adult cytogenetically normal acute myeloid leukemia patients in long-term remission.
    Sun Y; Shen H; Xu T; Yang Z; Qiu H; Sun A; Chen S; Wu D; Xu Y
    Leuk Res; 2016 Oct; 49():102-7. PubMed ID: 27626217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
    Wong TN; Ramsingh G; Young AL; Miller CA; Touma W; Welch JS; Lamprecht TL; Shen D; Hundal J; Fulton RS; Heath S; Baty JD; Klco JM; Ding L; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Graubert TA; Ley TJ; Druley T; Link DC; Wilson RK
    Nature; 2015 Feb; 518(7540):552-555. PubMed ID: 25487151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant
    Singh A; Mencia-Trinchant N; Griffiths EA; Altahan A; Swaminathan M; Gupta M; Gravina M; Tajammal R; Faber MG; Yan L; Sinha E; Hassane DC; Hayes DN; Guzman ML; Iyer R; Wang ES; Thota S
    JCO Precis Oncol; 2022 Jan; 6():e2100309. PubMed ID: 35025619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.
    Imi T; Katagiri T; Hosomichi K; Zaimoku Y; Hoang Nguyen V; Nakagawa N; Tajima A; Yoshizato T; Ogawa S; Nakao S
    Blood Adv; 2018 May; 2(9):1000-1012. PubMed ID: 29720492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal hematopoiesis with
    Stelmach P; Richter S; Sauer S; Fabre MA; Gu M; Rohde C; Janssen M; Liebers N; Proynova R; Weinhold N; Raab MS; Goldschmidt H; Besenbeck B; Pavel P; Laier S; Trumpp A; Dietrich S; Vassiliou GS; Müller-Tidow C
    Haematologica; 2023 Dec; 108(12):3308-3320. PubMed ID: 37381752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal hematopoiesis: Pre-cancer PLUS.
    Silver AJ; Jaiswal S
    Adv Cancer Res; 2019; 141():85-128. PubMed ID: 30691686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion.
    Tovy A; Reyes JM; Gundry MC; Brunetti L; Lee-Six H; Petljak M; Park HJ; Guzman AG; Rosas C; Jeffries AR; Baple E; Mill J; Crosby AH; Sency V; Xin B; Machado HE; Castillo D; Weitzel JN; Li W; Stratton MR; Campbell PJ; Wang H; Sanders MA; Goodell MA
    Cell Stem Cell; 2020 Aug; 27(2):326-335.e4. PubMed ID: 32673568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
    Ardestani MT; Kazemi A; Chahardouli B; Mohammadi S; Nikbakht M; Rostami S; Jalili M; Vaezi M; Alimoghaddam K; Ghavamzadeh A
    Turk J Haematol; 2018 Aug; 35(3):158-167. PubMed ID: 29786546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21.
    Zhang CR; Ostrander EL; Kukhar O; Mallaney C; Sun J; Haussler E; Celik H; Koh WK; King KY; Gontarz P; Challen GA
    Blood Cancer Discov; 2022 May; 3(3):220-239. PubMed ID: 35394496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.
    Zink F; Stacey SN; Norddahl GL; Frigge ML; Magnusson OT; Jonsdottir I; Thorgeirsson TE; Sigurdsson A; Gudjonsson SA; Gudmundsson J; Jonasson JG; Tryggvadottir L; Jonsson T; Helgason A; Gylfason A; Sulem P; Rafnar T; Thorsteinsdottir U; Gudbjartsson DF; Masson G; Kong A; Stefansson K
    Blood; 2017 Aug; 130(6):742-752. PubMed ID: 28483762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.
    Lindsley RC; Saber W; Mar BG; Redd R; Wang T; Haagenson MD; Grauman PV; Hu ZH; Spellman SR; Lee SJ; Verneris MR; Hsu K; Fleischhauer K; Cutler C; Antin JH; Neuberg D; Ebert BL
    N Engl J Med; 2017 Feb; 376(6):536-547. PubMed ID: 28177873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein phosphatase, Mg
    Husby S; Hjermind Justesen E; Grønbæk K
    Br J Haematol; 2021 Feb; 192(4):697-705. PubMed ID: 33616916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional role of DNMT3A mutation in acute myeloid leukemia].
    Koya J; Kurokawa M
    Rinsho Ketsueki; 2018; 59(5):602-610. PubMed ID: 29877252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation.
    Yasuda T; Ueno T; Fukumura K; Yamato A; Ando M; Yamaguchi H; Soda M; Kawazu M; Sai E; Yamashita Y; Murata M; Kiyoi H; Naoe T; Mano H
    Leukemia; 2014 Feb; 28(2):426-8. PubMed ID: 24067491
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis.
    Avagyan S; Henninger JE; Mannherz WP; Mistry M; Yoon J; Yang S; Weber MC; Moore JL; Zon LI
    Science; 2021 Nov; 374(6568):768-772. PubMed ID: 34735227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal hematopoiesis and risk of acute myeloid leukemia.
    Young AL; Tong RS; Birmann BM; Druley TE
    Haematologica; 2019 Dec; 104(12):2410-2417. PubMed ID: 31004019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.